About MPM PLC

Building Ethiopia's pharmaceutical manufacturing base.

MULU Pharmaceutical Manufacturing PLC was established to produce high-quality, affordable medicines locally and support a more resilient national healthcare supply chain.

52,200 sqm

manufacturing site

4

specialized production blocks

100+

planned essential medicines

8

dosage form categories

Company story

A local manufacturing response to a national supply challenge.

MPM PLC was founded in 2019 with a focused objective: reduce dependence on imported medicines by building reliable pharmaceutical production capacity in Ethiopia.

The company's manufacturing facility in Bahirdar, Amhara Region, spans 52,200 square meters and is structured around four dedicated production blocks for oral solids, beta-lactams, cephalosporins, and sterile or liquid formats.

The name MULU means complete or whole in Amharic. That idea is reflected in the company's planned portfolio, which spans common therapeutic needs and multiple dosage forms for public and private healthcare providers.

The Bahirdar site is positioned to serve Ethiopia first while preparing for regional export channels into neighboring markets. The long-term goal is a dependable manufacturing platform that supports national health security and economic self-reliance.

Operating model

Designed around quality, containment, and dependable supply.

The company story is grounded in practical operating choices: dedicated blocks, compliance-minded flows, and a portfolio focused on essential medicines.

Quality systems aligned with international GMP expectations

Dedicated production environments for sensitive product families

Local manufacturing capacity for essential medicines

Regional supply ambition built from an Ethiopian base

Roadmap

A phased path from construction to regional scale.

The timeline has been tightened into four executive milestones so visitors can quickly understand current state and next steps.

2024

Completed

Company founded and site secured

MPM PLC established, with a 52,200 sqm site secured in Bahirdar's Meshenty kebele designed around WHO GMP, PIC/S, and EFDA expectations.

2025

In progress

Facility buildout and commissioning

Construction, equipment installation, validation planning, and certification preparation across four manufacturing blocks.

2026

Planned

Production and regional scale

Launch essential medicines locally, expand portfolio depth, and establish export corridors into nearby markets.

Leadership

Governance and execution experience behind the facility buildout.

The leadership section is structured for credibility: founders and core operators are separated so stakeholders can see governance and delivery responsibilities clearly.

MMM

Mr. Mulugeta Marcus

Managing Director

A visionary Ethiopian entrepreneur with extensive experience in pharmaceutical import, distribution, and manufacturing. Mr. Mulugeta brings decades of industry knowledge and a deep commitment to building Ethiopia's local pharmaceutical production capacity.

MYA

Mr. Yonas Assefa

Board Member & Shareholder

A strategic investor and business leader bringing significant corporate governance expertise to MPM PLC. Mr. Yonas plays a critical role in shaping the company's strategic direction and building partnerships across the region.

AD

Alem Denekew

General Manager

Seasoned operations leader with deep expertise in pharmaceutical manufacturing management, regulatory compliance, and team building.

AH

Amanuel Haile

Project Manager

Expert in pharmaceutical facility design, equipment commissioning, and end-to-end project delivery for GMP-compliant manufacturing sites.

LS

Lulit Semunigus

Finance Manager

Experienced financial professional overseeing budgeting, financial planning, and fiscal controls for large-scale manufacturing operations.

BA

Bizuwork Abebe

Site Project Manager

On-site construction and infrastructure lead managing the day-to-day development of MPM PLC's 52,200 sqm manufacturing facility in Bahirdar.

Work with MPM PLC

Discuss partnerships, procurement, or investment.